Prophylactic Treatment With Atorvastatin for Episodic Migraine.

PHASE2RecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

February 28, 2029

Conditions
Episodic Migraine
Interventions
DRUG

Atorvastatin 40mg

Each tablet will be taken once daily for 84 days.

DRUG

Placebo

Each tablet will be taken once daily for 84 days

DRUG

Atorvastatin 20mg

Each tablet will be taken once daily for 84 days.

Trial Locations (6)

7022

RECRUITING

St. Olavs hospital, Trondheim

Unknown

RECRUITING

Haukeland University Hospital, Bergen

NOT_YET_RECRUITING

University Hospital, Akershus, Lørenskog

NOT_YET_RECRUITING

Oslo University Hospital, Rikshospitalet, Oslo

NOT_YET_RECRUITING

Oslo University Hospital, Ullevål, Oslo

RECRUITING

University Hospital Northern Norway, Tromsø

All Listed Sponsors
collaborator

Haukeland University Hospital

OTHER

collaborator

Oslo University Hospital

OTHER

collaborator

University Hospital of North Norway

OTHER

collaborator

University Hospital, Akershus

OTHER

collaborator

Ullevaal University Hospital

OTHER

lead

St. Olavs Hospital

OTHER

NCT06248671 - Prophylactic Treatment With Atorvastatin for Episodic Migraine. | Biotech Hunter | Biotech Hunter